Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

TSLA Stock: Elon Musk Says Tesla Board Will Review xAI Investment Proposal

Tesla CEO Elon Musk is a man that pushes limits. But will this recent proposal be the straw that breaks the back of TSLA stock?

TD Cowen Just Cut Its Price Target on QuantumScape (QS) Stock

After QuantumScape reported earnings, an analyst downgrade is among the key catalysts which has taken QS stock lower today.

CMG Stock Analysis: Should You Buy Chipotle Following Its Recent Q2 Report?

Let's dive into whether CMG stock is worth adding to investor portfolios right now or if now may be the time to pump the brakes.

The 3 Stocks Every Investor Should Be Selling in July

Here are three stocks to sell for investors who may want to seek out speculative opportunities in this difficult to digest market.

Could Alphabet Be the Sneaky Cybersecurity Stock to Buy Now?

Dive into whether Alphabet fits the profile of most long-term investments, and whether GOOG stock could be the next cybersecurity play.

MSFT Stock Outlook: Is MSFT Still a Buy After the Massive CrowdStrike Outage?

Microsoft investors have certainly seen some volatility in recent days, but there's reason to believe MSFT stock could still be a top stock.

Why Is Lucid Motors (LCID) Stock Down Today?

Shares of LCID stock are once again tanking today, as investors digest the dismal results put out by U.S. EV leader Tesla yesterday.

Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?

Little-known firm Sangamo Therapeutics is surging today, with SGMO stock up more than 40% on promising late-stage trial results.

Broadcom Stock Alert: Is Now the Best Time to Buy AVGO Shares?

The chipmaker is among the top chip stocks long-term investors are ignoring, but Broadcom stock could be poised for big gains.

3 Dividend Stocks That Could Easily Double From Here

Here are three top dividend stocks that have the potential to double from here, assuming we don't get a recession and growth continues.